Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer

The effects of treatments to programmed death ligand-1 (PD-L1) expression is unknown. The aim of this study was to investigate the impact of neoadjuvant chemotherapy (NACT) on PD-L1 expression in non-small cell lung cancer (NSCLC) patients. PD-L1 expression was detected by immunohistochemistry (IHC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Jin, Fang, Wenfeng, Yu, Juan, Chen, Nan, Zhan, Jianhua, Ma, Yuxiang, Yang, Yunpeng, Yanhuang, Zhao, Hongyun, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731819/
https://www.ncbi.nlm.nih.gov/pubmed/26822379
http://dx.doi.org/10.1038/srep20090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731819/
https://www.ncbi.nlm.nih.gov/pubmed/26822379
http://dx.doi.org/10.1038/srep20090

Ejemplares similares